Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003476789 | SCV004201412 | likely pathogenic | Peroxisome biogenesis disorder 6A (Zellweger) | 2023-01-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003535028 | SCV004313707 | pathogenic | Peroxisome biogenesis disorder, complementation group 7 | 2023-08-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with PEX10-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Pro3Argfs*9) in the PEX10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX10 are known to be pathogenic (PMID: 9683594, 10862081, 21031596). |